BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31597849)

  • 21. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
    Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
    Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
    Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early genetic events provide the basis for a clinical classification of multiple myeloma.
    Kuehl WM; Bergsagel PL
    Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in biology and therapy of multiple myeloma.
    Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
    Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].
    Wang YF; Wang H; Xi LY; Liu Y; Dong F; Wang JJ; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1352-6. PubMed ID: 26524036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A molecular study of the t(4;14) in multiple myeloma.
    Sibley K; Fenton JA; Dring AM; Ashcroft AJ; Rawstron AC; Morgan GJ
    Br J Haematol; 2002 Aug; 118(2):514-20. PubMed ID: 12139740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
    Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
    Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
    Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
    Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).
    Våtsveen TK; Brenne AT; Dai HY; Waage A; Sundan A; Børset M
    Eur J Haematol; 2009 Nov; 83(5):471-6. PubMed ID: 19594619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene Mutation and Overexpression of Newly Diagnosed Multiple Myeloma Patients].
    Fan Y; Wang SJ; Liu YF; Wang C; Li YF; Wang WQ; Hao QQ; Zhang DF; Li YM; Sun H; Guo R; Chen SQ; Xie XS; Li T; Wan DM; Jiang ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):166-169. PubMed ID: 35123621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
    Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies FE; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan GJ
    Blood; 2018 Aug; 132(6):587-597. PubMed ID: 29884741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.
    Bahmanyar M; Qi X; Chang H
    Leuk Res; 2013 Dec; 37(12):1726-8. PubMed ID: 24169086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma.
    Paner A; Patel P; Dhakal B
    Blood Rev; 2020 May; 41():100643. PubMed ID: 31818702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation.
    Diamantidis MD; Papadaki S; Hatjiharissi E
    Front Oncol; 2022; 12():934008. PubMed ID: 35982976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.
    White BS; Lanc I; O'Neal J; Gupta H; Fulton RS; Schmidt H; Fronick C; Belter EA; Fiala M; King J; Ahmann GJ; DeRome M; Mardis ER; Vij R; DiPersio JF; Levy J; Auclair D; Tomasson MH
    Blood Cancer J; 2018 Mar; 8(3):35. PubMed ID: 29563506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetics and Survival of Multiple Myeloma: Isolated and Combined Effects.
    Sergentanis TN; Kastritis E; Terpos E; Dimopoulos MA; Psaltopoulou T
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):335-40. PubMed ID: 27101987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
    Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
    Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing.
    Ryland GL; Jones K; Chin M; Markham J; Aydogan E; Kankanige Y; Caruso M; Guinto J; Dickinson M; Prince HM; Yong K; Blombery P
    J Clin Pathol; 2018 Oct; 71(10):895-899. PubMed ID: 29760015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.